Skip to main content
main-content

Epidemiology and prevention

Epidemiology and prevention

12-09-2017 | Kaposi sarcoma | Article

The pattern of secondary cancers in patients with Kaposi sarcoma in the United States

This study finds that the absolute risk of non-AIDS-defining secondary cancers is higher in Kaposi sarcoma patients in the HAART era, yet the overall relative risk of secondary cancers has decreased.

Kumar V et al. Cancer Causes Control 2017; 28: 1065-1074. doi:10.1007/s10552-017-0957-0

25-08-2017 | Sarcoma | Article

Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

In the largest study of extramedullary myeloid sarcoma in the US, the authors use the National Cancer Database to describe the clinical features, prognostic factors and early treatment outcomes.

Blood Cancer J 2017; 7: e592. doi:10.1038/bcj.2017.79

Authors:
G Goyal, A C Bartley, M M Patnaik, , A Al-Kali, R S Go

01-11-2016 | Sarcoma | Article

An Update on Kaposi’s Sarcoma: Epidemiology, Pathogenesis and Treatment

It is important for clinicians to be mindful of Kaposi’s sarcoma manifesting in a growing variety of clinical contexts. Here, Curtiss et al. provide an update on the epidemiology and treatment of this tumor.

Curtiss P, Strazzulla LC, & Friedman-Kien AE. Dermatol Ther (Heidelb) 2016;6:465–470. doi:10.1007/s13555-016-0152-3